Status:
COMPLETED
Study Evaluating Effexor XR for Major Depression.
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Depression
Eligibility:
All Genders
20-64 years
Phase:
PHASE3
Brief Summary
Study Evaluating Effexor XR for Major Depression.
Eligibility Criteria
Inclusion
- Patients diagnosed with major depression based on DSM-IV-TR
- Patients having minimal total score of 18 on the HAM-D17 and minimal score of 2 on the item of "depressed mood" at the baseline.
Exclusion
- Patients with schizophrenia or any other psychotic disorder
- Patients with history or presence of bipolar disorder
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
590 Patients enrolled
Trial Details
Trial ID
NCT00225511
Start Date
June 1 2004
Last Update
May 24 2007
Active Locations (73)
Enter a location and click search to find clinical trials sorted by distance.
1
Nagoya, Aichi-ken, Japan, 462-0831
2
Nagoya, Aichi-ken, Japan, 467-8602
3
Ichikawa, Chiba, Japan, 272-0034
4
Ichikawa, Chiba, Japan, 272-0827